KOSDAQ · Healthcare · ₩816B
₩21,800+0.23%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 17.0% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“신약 성과를 기다리며 투자를 이어가는 단계예요.”
In the company's words · 2026 2분기 filing